Advertisement
Clinical Review|Articles in Press

A NARRATIVE REVIEW OF THE EVALUATION AND MANAGEMENT OF LIVER TRANSPLANT COMPLICATIONS IN THE EMERGENCY DEPARTMENT

      Abstract

      Background: Liver transplant recipients are prone to both short-term and long-term complications and may present to any emergency department. Objective: This narrative review summarized key aspects of liver transplantation and reviewed the major complications that may result in emergency department presentation. Discussion: Liver transplantation is the only curative therapy for end-stage liver disease and the liver is the second most commonly transplanted solid organ. With nearly 100,000 living liver transplant recipients in the United States, these patients no longer present exclusively to transplantation centers. Critical complications may manifest with a variety of subtle signs and symptoms that must be considered by the emergency physician. Appropriate evaluation often includes laboratory analysis and imaging. Treatment may be time-sensitive and is variable depending on the specific complication. Conclusions: Emergency physicians in all settings must be prepared to evaluate and treat liver transplant recipients who present with potential graft- and life-threatening complications.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Emergency Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

        • Kwong AJ
        • Ebel NH
        • Kim WR
        • et al.
        OPTN/SRTR 2020 annual data report: liver.
        Am J Transplant. 2022; 22: 204-309
        • Savitsky EA
        • Votey SR
        • Mebust DP
        • Schwartz E
        • Uner AB
        • McCain S.
        A descriptive analysis of 290 liver transplant patient visits to an emergency department.
        Acad Emerg Med. 2000; 7: 898-905
        • McElroy LM
        • Schmidt KA
        • Richards CT
        • et al.
        Early postoperative emergency department care of abdominal transplant recipients.
        Transplantation. 2015; 99: 1652-1657
        • Mıhçıokur S
        • Ayvazoğlu Soy EH
        • Türkçelik E
        • Akın A
        • Haberal M
        Gender imbalance and the relationship between living donors and recipients in liver transplantations in an organ transplant center in Turkey.
        Exp Clin Transplant. 2019; 17: 131-134
        • Oh SY
        • Lee JM
        • Lee H
        • et al.
        Emergency department visits and unanticipated readmissions after liver transplantation: a retrospective observational study.
        Sci Rep. 2018; 8: 4084
        • Nishida S
        • Nakamura N
        • Vaidya A
        • et al.
        Piggyback technique in adult orthotopic liver transplantation: an analysis of 1067 liver transplants at a single center.
        HPB (Oxford). 2006; 8: 182-188
        • Barritt 4th, AS
        • Miller CB
        • Hayashi PH
        • Dellon ES
        Effect of ERCP utilization and biliary complications on post-liver-transplantation mortality and graft survival.
        Dig Dis Sci. 2010; 55: 3602-3609
        • Ito T
        • Botros M
        • Aziz A
        • et al.
        Nonanastomotic biliary strictures after liver transplantation.
        Am Surg. 2020; 86: 1363-1367
        • Feier FH
        • Seda-Neto J
        • da Fonseca EA
        • et al.
        Analysis of factors associated with biliary complications in children after liver transplantation.
        Transplantation. 2016; 100: 1944-1954
        • Kochhar G
        • Parungao JM
        • Hanouneh IA
        • Parsi MA.
        Biliary complications following liver transplantation.
        World J Gastroenterol. 2013; 19: 2841-2846
        • Frongillo F
        • Grossi U
        • Lirosi MC
        • et al.
        Incidence, management, and results of hepatic artery stenosis after liver transplantation in the era of donor to recipient match.
        Transplant Proc. 2013; 45: 2722-2725
        • Orons PD
        • Sheng R
        • Zajko AB.
        Hepatic artery stenosis in liver transplant recipients: prevalence and cholangiographic appearance of associated biliary complications.
        AJR Am J Roentgenol. 1995; 165: 1145-1149
        • Bastón Castiñeiras M
        • Benítez Linero I
        • Serrano Zarcero V
        • et al.
        Hepatic artery thrombosis after orthotopic liver transplant: experience in the last 10 years.
        Transplant Proc. 2022; 54: 51-53
        • Bhattacharjya S
        • Gunson BK
        • Mirza DF
        • et al.
        Delayed hepatic artery thrombosis in adult orthotopic liver transplantation-a 12-year experience.
        Transplantation. 2001; 71: 1592-1596
        • Wu L
        • Zhang J
        • Guo Z
        • et al.
        Hepatic artery thrombosis after orthotopic liver transplant: a review of the same institute 5 years later.
        Exp Clin Transplant. 2011; 9: 191-196
        • Naidu S
        • Alzubaidi S
        • Knuttinen G
        • et al.
        Treatment of hepatic artery stenosis in liver transplant patients using drug-eluting versus bare-metal stents.
        J Clin Med. 2021; 10: 380
        • Leelaudomlipi S
        • Bramhall SR
        • Gunson BK
        • et al.
        Hepatic-artery aneurysm in adult liver transplantation.
        Transpl Int. 2003; 16: 257-261
        • Zhang J
        • Khalifeh A
        • Santini-Dominguez R
        • et al.
        Endovascular reconstruction of the hepatic arterial system for the management of mycotic pseudoaneurysm in a liver transplant patient.
        Ann Vasc Surg. 2019; 61 (473.e7–473.e11)
        • Soong RS
        • Pan KT
        • Lee CF
        • Lee WC.
        Hepatic artery-duodenal fistula with gastrointestinal bleeding after liver transplantation.
        Chang Gung Med J. 2009; 32: 579-583
        • Piardi T
        • Lhuaire M
        • Bruno O
        • et al.
        Vascular complications following liver transplantation: a literature review of advances in 2015.
        World J Hepatol. 2016; 8: 36-57
        • Cos H
        • Ahmed O
        • Garcia-Aroz S
        • et al.
        Incisional hernia after liver transplantation: risk factors, management strategies and long-term outcomes of a cohort study.
        Int J Surg. 2020; 78: 149-153
        • Cortes M
        • Tapuria N
        • Khorsandi SE
        • et al.
        Diaphragmatic hernia after liver transplantation in children: case series and review of the literature.
        Liver Transpl. 2014; 20: 1429-1435
        • Martin V
        • Gregoire E
        • Chopinet S
        • et al.
        Acquired diaphragmatic hernia after hepatectomy and liver transplantation in adults and children: a case series and literature review.
        Ann Hepatobiliary Pancreat Surg. 2021; 25: 462-471
        • Heldman MR
        • Ngo S
        • Dorschner PB
        • Helfrich M
        • Ison MG.
        Pre- and post-transplant bacterial infections in liver transplant recipients.
        Transpl Infect Dis. 2019; 21: e13152https://doi.org/10.1111/tid.13152
        • Hernandez MDP
        • Martin P
        • Simkins J.
        Infectious complications after liver transplantation.
        Gastroenterol Hepatol (N Y). 2015; 11: 741-753
        • Hreńczuk M
        • Biedrzycka A
        • Łągiewska B
        • Kosieradzki M
        • Małkowski P.
        Surgical site infections in liver transplant patients: a single-center experience.
        Transplant Proc. 2020; 52: 2497-2502
        • Taylor JS
        • Marten CA
        • Potts KA
        • et al.
        What is the real rate of surgical site infection?.
        J Oncol Pract. 2016; 12: e878-e883https://doi.org/10.1200/JOP.2016.011759
        • Natori Y
        • Kassar R
        • Iaboni A
        • et al.
        Surgical site infections after liver transplantation: prospective surveillance and evaluation of 250 transplant recipients in Canada.
        Infect Control Hosp Epidemiol. 2017; 38: 1084-1090
        • Marcelin JR
        • Beam E
        • Razonable RR.
        Cytomegalovirus infection in liver transplant recipients: updates on clinical management.
        World J Gastroenterol. 2014; 20: 10658-10667
        • Kose A
        • Toplu SA
        • Yalcinsoy M
        • et al.
        Clinical characteristics and outcomes of liver transplantation recipients with COVID-19 pneumonia.
        Transplant Proc. 2021; 53: 2481-2489
        • Hadi YB
        • Naqvi SFZ
        • Kupec JT
        • Sofka S
        • Sarwari A.
        Outcomes of COVID-19 in solid organ transplant recipients: a propensity-matched analysis of a large research network.
        Transplantation. 2021; 105: 1365-1371
        • Avery RK
        • Chiang TP
        • Marr KA
        • et al.
        Inpatient COVID-19 outcomes in solid organ transplant recipients compared to non-solid organ transplant patients: a retrospective cohort.
        Am J Transplant. 2021; 21: 2498-2508
        • Savitsky EA
        • Uner AB
        • Votey SR.
        Evaluation of orthotopic liver transplant recipients presenting to the emergency department.
        Ann Emerg Med. 1998; 31: 507-517
        • Choudhary NS
        • Saigal S
        • Bansal RK
        • Saraf N
        • Gautam D
        • Soin AS.
        Acute and chronic rejection after liver transplantation: what a clinician needs to know.
        J Clin Exp Hepatol. 2017; 7: 358-366
        • Roberts MB
        • Fishman JA.
        Immunosuppressive agents and infectious risk in transplantation: managing the "net state of immunosuppression".
        Clin Infect Dis. 2021; 73: e1302-e1317https://doi.org/10.1093/cid/ciaa1189
        • Taner T.
        Liver transplantation: rejection and tolerance.
        Liver Transpl. 2017; 23: S85-S88
      1. Charlton M, Levitsky J, Aqel B, et al. International Liver Transplantation Society consensus statement on immunosuppression in liver transplant recipients. Transplantation 2018;102:727–43. Erratum in: Transplantation 2019;103(1):e37.

        • Halloran PF.
        Immunosuppressive drugs for kidney transplantation.
        N Engl J Med. 2004; 351 (Erratum in: N Engl J Med 2005;352(10):1056): 2715-2729
        • Kwong AJ
        • Kim WR
        • Lake JR
        • et al.
        OPTN/SRTR 2019 annual data report: liver.
        Am J Transplant. 2021; 21: 208-315
        • Bittermann T
        • Hubbard RA
        • Lewis JD
        • Goldberg DS.
        The use of induction therapy in liver transplantation is highly variable and is associated with posttransplant outcomes.
        Am J Transplant. 2019; 19: 3319-3327
        • Prograf
        Prescribing information.
        Astellas Pharma US Inc. October 19, 2022; (Accessed)
        • Rapamune
        Prescribing information.
        Wyeth Pharmaceuticals LLC. October 19, 2022; (Accessed)
        • Trofe-Clark J
        • Lemonovich TL
        AST Infectious Diseases Community of Practice. Interactions between anti-infective agents and immunosuppressants in solid organ transplantation.
        Am J Transplant. 2013; 13: 318-326
        • Gonultas F
        • Akbulut S
        • Barut B
        • Kutluturk K
        • Yilmaz S.
        Graft-versus-host disease after living donor liver transplantation: an unpredictable troublesome complication for liver transplant centers.
        Eur J Gastroenterol Hepatol. 2020; 32: 95-100
        • Murali AR
        • Chandra S
        • Stewart Z
        • et al.
        Graft versus host disease after liver transplantation in adults: a case series, review of literature, and an approach to management.
        Transplantation. 2016; 100: 2661-2670
        • Romero S
        • Montoro J
        • Guinot M
        • et al.
        Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation.
        Leuk Lymphoma. 2019; 60: 142-150
        • Kamdar KY
        • Rooney CM
        • Heslop HE.
        Posttransplant lymphoproliferative disease following liver transplantation.
        Curr Opin Organ Transplant. 2011; 16: 274-280
        • Kataoka K
        • Seo S
        • Sugawara Y
        • et al.
        Post-transplant lymphoproliferative disorder after adult-to-adult living donor liver transplant: case series and review of literature.
        Leuk Lymphoma. 2010; 51: 1494-1501
        • Modaresi Esfeh J
        • Hanouneh IA
        • Dalal D
        • et al.
        The incidence and risk factors of de novo skin cancer in the liver transplant recipients.
        Int J Organ Transplant Med. 2012; 3: 157-163
        • Lucidi C
        • Biolato M
        • Lai Q
        • et al.
        Cumulative incidence of solid and hematological De novo malignancy after liver transplantation in a multicentre cohort.
        Ann Hepatol. 2021; 24100309https://doi.org/10.1016/j.aohep.2021.100309
        • Dumortier J
        • Maucort-Boulch D
        • Poinsot D
        • et al.
        Immunosuppressive regimen and risk for de novo malignancies after liver transplantation for alcoholic liver disease.
        Clin Res Hepatol Gastroenterol. 2018; 42: 427-435
        • Leidig-Bruckner G
        • Hosch S
        • Dodidou P
        • et al.
        Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study.
        Lancet. 2001; 357: 342-347
        • Buzelé R
        • Zarrouk V
        • Francoz C
        • Durand F
        • Fantin B.
        Characteristics of vertebral osteomyelitis after liver transplantation.
        Clin Microbiol Infect. 2015; 21: 573-577
        • Zivković SA.
        Neurologic complications after liver transplantation.
        World J Hepatol. 2013; 5: 409-416
        • Weber ML
        • Ibrahim HN
        • Lake JR.
        Renal dysfunction in liver transplant recipients: evaluation of the critical issues.
        Liver Transpl. 2012; 18: 1290-1301
        • De Luca L
        • Kalafateli M
        • Bianchi S
        • et al.
        Cardiovascular morbidity and mortality is increased post-liver transplantation even in recipients with no pre-existing risk factors.
        Liver Int. 2019; 39: 1557-1565
        • Maestas C
        • Lazkani M
        • Sultan M
        • Kolli G
        • Sheikh M
        • Cherukuri M.
        Severe takotsubo cardiomyopathy following orthotopic liver transplantation: a case series.
        Clin Res Hepatol Gastroenterol. 2019; 43: e48-e53https://doi.org/10.1016/j.clinre.2018.11.009
        • Keshavarz R
        • Mousavi MA
        • Hassani C.
        Diabetic ketoacidosis in a child on FK506 immunosuppression after a liver transplant.
        Pediatr Emerg Care. 2002; 18: 22-24
        • Yoshida EM
        • Buczkowski AK
        • Sirrs SM
        • et al.
        Post-transplant diabetic ketoacidosis—a possible consequence of immunosuppression with calcineurin inhibiting agents: a case series.
        Transpl Int. 2000; 13: 69-72
        • Terto SV
        • Araújo ST
        • Negreiros FDDS
        • et al.
        Risk factors associated with new-onset diabetes after liver transplant: a case control study.
        Transplant Proc. 2019; 51: 1956-1961
        • Ling Q
        • Xu X
        • Wang B
        • Li L
        • Zheng S.
        The origin of new-onset diabetes after liver transplantation: liver, islets, or gut?.
        Transplantation. 2016; 100: 808-813
        • Hong Z
        • Wu J
        • Smart G
        • et al.
        Survival analysis of liver transplant patients in Canada 1997-2002.
        Transplant Proc. 2006; 38: 2951-2956
        • Durán FG
        • Piqueras B
        • Romero M
        • et al.
        Pulmonary complications following orthotopic liver transplant.
        Transpl Int. 1998; 11: S255-S259
        • Kohli-Seth R
        • Killu C
        • Amolat MJ
        • et al.
        Bronchiolitis obliterans organizing pneumonia after orthotopic liver transplantation.
        Liver Transpl. 2004; 10: 456-459
        • DeAngelo AJ
        • Ouellette D.
        Bronchiolitis obliterans organizing pneumonia in an orthotopic liver transplant patient.
        Transplantation. 2002; 73: 544-546
        • Emuakhagbon V
        • Philips P
        • Agopian V
        • Kaldas FM
        • Jones CM.
        Incidence and risk factors for deep venous thrombosis and pulmonary embolus after liver transplantation.
        Am J Surg. 2016; 211: 768-771
        • Salami A
        • Qureshi W
        • Kuriakose P
        • Moonka D
        • Yoshida A
        • Abouljoud M.
        Frequency and predictors of venous thromboembolism in orthotopic liver transplant recipients: a single-center retrospective review.
        Transplant Proc. 2013; 45: 315-319
        • Deshpande NA
        • James NT
        • Kucirka LM
        • et al.
        Pregnancy outcomes of liver transplant recipients: a systematic review and meta-analysis.
        Liver Transpl. 2012; 18: 621-629
        • Sobotka LA
        • Mumtaz K
        • Hinton A
        • Conteh LF.
        Pregnancy in liver transplantation recipients is associated with increased complications and healthcare utilization.
        Am J Gastroenterol. 2021; 116: 560-567
        • Caiado AH
        • Blasbalg R
        • Marcelino AS
        • et al.
        Complications of liver transplantation: multimodality imaging approach.
        Radiographics. 2007; 27: 1401-1417
        • Girometti R
        • Cereser L
        • Como G
        • Zuiani C
        • Bazzocchi M.
        Biliary complications after orthotopic liver transplantation: MRCP findings.
        Abdom Imaging. 2008; 33: 542-554